Correlation Between Pmv Pharmaceuticals and CSL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and CSL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and CSL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and CSL, you can compare the effects of market volatilities on Pmv Pharmaceuticals and CSL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of CSL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and CSL.

Diversification Opportunities for Pmv Pharmaceuticals and CSL

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Pmv and CSL is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and CSL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSL and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with CSL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSL has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and CSL go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and CSL

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 2.89 times more return on investment than CSL. However, Pmv Pharmaceuticals is 2.89 times more volatile than CSL. It trades about 0.25 of its potential returns per unit of risk. CSL is currently generating about 0.14 per unit of risk. If you would invest  87.00  in Pmv Pharmaceuticals on May 17, 2025 and sell it today you would earn a total of  68.00  from holding Pmv Pharmaceuticals or generate 78.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Pmv Pharmaceuticals  vs.  CSL

 Performance 
       Timeline  
Pmv Pharmaceuticals 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Pmv Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
CSL 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CSL are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile essential indicators, CSL may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pmv Pharmaceuticals and CSL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pmv Pharmaceuticals and CSL

The main advantage of trading using opposite Pmv Pharmaceuticals and CSL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, CSL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSL will offset losses from the drop in CSL's long position.
The idea behind Pmv Pharmaceuticals and CSL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stocks Directory
Find actively traded stocks across global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk